News from Clinical Trials Arena
If you want to know if Clinical Trials Arena is credible or reliable, look no further. We rank Clinical Trials Arena as Unknown factuality. Find out more about our methodology here.
Information about Clinical Trials Arena
Where is Clinical Trials Arena located?Clinical Trials Arena's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Clinical Trials Arena News

Eli Lilly(Reuters) -Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for alopecia and eczema. The company was testing baricitinib, sold under the brand name Olumiant, in 257 adolescent patients with severe alopecia areata or patchy hair loss. In the trial, a 4 milligram dose of baricitinib helped improve hair regrowth in more than 50% of adolescents after one year of treatment. Succ…See the Story
Eli Lilly Reports Promising Data for Alopecia and Eczema Drugs, Eyes Label Expansion - Regional Media News
100% Center coverage: 1 sources

